Search
Request a Quote

Structure-Guided Rational Design

Enzyme Engineering Services

Structure-Guided Rational Design

Design targeted enzyme variants and inhibitor scaffolds from 3D structural data, then validate them experimentally with kinetic and binding assays.

Structure retrieval or homology modeling of your target protein
Active-site and binding-pocket analysis with docking or MD simulation
Designed variants expressed, purified, and tested for activity and stability

Input

Structure or Model

Every project starts from a resolved structure or a homology model built for your target when no experimental structure is available.

  • Experimental structure retrieval from public databases
  • Homology modeling for uncharacterized homologs
  • Model quality assessment before design begins
Analysis

Site and Pocket Mapping

Active-site and binding-pocket residues are mapped to identify positions that plausibly govern the property you want to change.

  • Active-site and substrate-pocket analysis
  • Docking of substrates, ligands, or inhibitor scaffolds
  • Molecular dynamics for flexibility and contact stability
Output

Designed Candidates

The deliverable is a defined set of designed proteins or inhibitor scaffolds with a documented structural rationale for each.

  • Rational point mutations or inhibitor scaffolds
  • Ranked candidate list with predicted impact
  • Experimental validation of designed variants

Where It Fits

Structure-guided design is most useful when structural information exists or can be modeled and when the goal is to tune a known scaffold rather than discover an entirely new one. It complements empirical approaches by reducing the number of variants that must be built and screened.

Typical programs include improving catalytic activity or substrate specificity, raising thermostability, shifting cofactor preference, and optimizing inhibitor potency or selectivity against a validated target.

ObjectiveStructural Starting PointTypical Design ActionReadout
Improve catalytic activityResolved structure or homology modelMutate active-site or second-shell residuesKinetic parameters
Alter substrate specificitySubstrate-bound or docked complexReshape binding-pocket contactsSubstrate panel activity
Increase thermostabilityStructure plus MD flexibility analysisReinforce packing or introduce stabilizing contactsThermal stability and residual activity
Shift cofactor preferenceCofactor-bound structure or modelAdjust cofactor-binding pocket residuesCofactor-dependent activity
Improve inhibitor potencyTarget structure with bound ligandOptimize scaffold interactions in the pocketBinding affinity
Improve inhibitor selectivityComparative structures of related targetsExploit divergent pocket residuesSelectivity profiling

How Engagement Works

Projects follow an iterative design-test-learn cycle. Each round produces designed candidates, experimental data on those candidates, and a structural interpretation that informs the next round.

1

Structure Acquisition

We retrieve an experimental structure for your target or build a homology model, then assess model quality to confirm it is suitable for design work.

2

Site and Pocket Analysis

Active-site and binding-pocket residues are mapped, and docking or molecular dynamics simulations are used to identify positions that plausibly control the target property.

3

Rational Candidate Design

We select a focused set of point mutations or inhibitor scaffolds with a documented structural rationale, prioritizing changes with the strongest predicted impact.

4

Variant Production and Assay

Designed proteins are expressed and purified, or designed compounds are prepared, then tested in enzymatic activity, binding affinity, or stability assays.

What You Can Customize

Scope is defined per project after consultation, so the design depth, candidate count, and validation package match your program stage rather than a fixed bundle.

Structure

Starting Structural Input

Projects can begin from a public experimental structure, a client-supplied model, or a homology model we build for an uncharacterized homolog.

  • Experimental structure retrieval
  • Client-supplied structural models
  • Homology modeling for related sequences
Computation

Simulation Depth

The computational package can range from docking and hotspot mapping to longer molecular dynamics runs for flexibility and contact stability.

  • Docking of substrates or ligands
  • Molecular dynamics simulations
  • Hotspot and contact-network mapping
Design

Candidate Strategy

We can focus on single-residue changes, combinatorial sets of predicted positions, or inhibitor scaffold optimization depending on the objective.

  • Single point mutations
  • Combined mutation sets
  • Inhibitor scaffold optimization

Service Scope

The table below describes what can be customized case by case. Final scope, candidate counts, and validation depth are agreed in the project statement of work.

ParameterTypical Project ScopeOptionsNotes
Structural inputExperimental structure or homology modelRetrieval, client-supplied, or modeledModel quality assessed before design
Site analysisActive-site and binding-pocket mappingSingle site or comparative multi-targetScoped to the engineering objective
Computational methodsDocking and molecular dynamicsDocking only or extended MDSelected per project complexity
Designed candidatesFocused set of predicted variantsQuantity scoped per projectRanked by predicted impact
ProductionRecombinant expression and purificationProtein variants or synthesized compoundsAs scoped for the target class
Validation assaysActivity, binding, or stability testingSingle assay or combined panelMatched to the engineered property
Iteration roundsDesign-test-learn cyclesNumber of rounds scoped per projectContinues until target property is met
ReportingStructural rationale and experimental dataStandard or extended data packageDelivered at project milestones

Why Structure-Guided

Rational design grounds engineering decisions in interpretable structural principles, which makes each candidate easier to justify and each result easier to interpret than a purely empirical campaign.

Focus

Smaller Candidate Sets

Because positions are chosen from structural evidence, the number of variants that must be built and tested is kept deliberately small.

  • Hypothesis-driven residue selection
  • Ranked candidates by predicted impact
  • Fewer wasted build-and-test cycles
Mechanism

Interpretable Results

Each experimental outcome can be traced back to a structural prediction, which supports mechanistic understanding rather than a black-box hit.

  • Documented structural rationale
  • Prediction compared against assay data
  • Findings feed the next design round
Fit

Complements Empirical Work

Structure-guided design pairs well with existing screening or evolution campaigns by focusing effort where structural evidence points.

  • Useful when a scaffold already exists
  • Reduces reliance on large libraries
  • Iterative refinement across rounds

ItemDetailBasisNotes
Target classEnzymes, proteins, or inhibitor targetsClient-supplied sequence or structureConfirmed during scoping
Structural inputExperimental structure or homology modelPublic database or modelingQuality assessed first
Design outputDesigned protein variants or inhibitor scaffoldsScoped per projectRanked with rationale
Validation dataKinetic, binding, or stability resultsAssay panel as scopedReported per milestone
IterationDesign-test-learn roundsNumber scoped per projectContinues to target property
Technical supportNamed scientific contact at project start; milestone review calls; email response within 1 business day.Standard across projectsSingle contact line

Applications

Structure-guided rational design has been applied across enzyme and inhibitor programs, from lipases and esterases to therapeutic target inhibitors. The examples below reflect published work in this area and illustrate the kinds of objectives the approach supports.

Enzymes

Activity and Specificity

Published work has used structure-guided design to alter substrate specificity and catalytic activity, including single-residue changes that measurably shift hydrolysis behavior.

  • Substrate specificity engineering
  • Catalytic activity improvement
  • Single-residue mutant effects
Stability

Thermostability

Structural analysis has been used to improve enzyme thermostability by reinforcing packing and stabilizing contacts identified from the model.

  • Thermostability improvement
  • Packing and contact reinforcement
  • Residual activity testing
Inhibitors

Potency and Selectivity

Structure-guided design has supported discovery of selective inhibitors against validated targets, with potency assessed through binding affinity measurements.

  • Selective inhibitor discovery
  • Scaffold optimization
  • Binding affinity assessment

Getting Started

Share your target sequence or structure, the property you want to change, and any existing assay data. We will confirm whether a structure or model is available and outline a design plan.

Scope, candidate counts, and validation depth are agreed in the statement of work before the project begins.

FAQ

What if no experimental structure exists for my target?

We can build a homology model from related sequences and assess its quality before design begins. Model-based design is commonly used when no experimental structure is available, and the confidence of predictions is reported alongside the candidate list.

How is this different from directed evolution?

Directed evolution relies on random mutagenesis and high-throughput screening without requiring structural knowledge. Structure-guided rational design uses 3D structural data to make targeted, hypothesis-driven changes, so a smaller set of predicted candidates is built and tested instead of a large random library.

What do I receive at the end of a project?

Deliverables typically include a documented structural rationale, a ranked set of designed protein variants or inhibitor scaffolds, and experimental validation data such as activity, binding affinity, kinetic, or stability results, depending on the property being engineered.

Can you work with inhibitor targets as well as enzymes?

Yes. The same structural workflow supports inhibitor scaffold optimization against validated targets, where binding-pocket analysis and docking guide design and binding affinity assays provide the readout. The specific assay panel is scoped per project.

How many design rounds will my project need?

The number of design-test-learn rounds depends on the target property and how closely the initial predictions match experimental results. Round count is scoped per project, and the cycle continues until the desired property is achieved or the agreed scope is met.

References

  1. Choi JM, Kim HS. Structure-guided rational design of the substrate specificity and catalytic activity of an enzyme. Methods in enzymology. 2020;643:181-202. View on PubMed
  2. Lan D, Zhao G, Holzmann N, et al. Structure-Guided Rational Design of a Mono- and Diacylglycerol Lipase from Aspergillus oryzae: A Single Residue Mutant Increases the Hydrolysis Ability. Journal of agricultural and food chemistry. 2021;69(18):5344-5352. View on PubMed
  3. Yang W, Sun L, Dong P, et al. Structure-guided rational design of the Geobacillus thermoglucosidasius feruloyl esterase GthFAE to improve its thermostability. Biochemical and biophysical research communications. 2022;600:117-122. View on PubMed
  4. Mobeen B, Shah M, Rehman HM, et al. Discovery of the selective and nanomolar inhibitor of DPP-4 more potent than sitagliptin by structure-guided rational design. European journal of medicinal chemistry. 2024;279:116834. View on PubMed
  5. Gao Q, Ma B, Wang Q, et al. Improved 2α-Hydroxylation Efficiency of Steroids by CYP154C2 Using Structure-Guided Rational Design. Applied and environmental microbiology. 2023;89(3):e0218622. View on PubMed

Start a Structure-Guided Design Project

Send us your target sequence or structure and the property you want to engineer. We will confirm structural feasibility and outline a design plan for your review.

Discuss Your Target

Online Inquiry

For research and industrial use only, not for personal medicinal use.

Submit